Respiratory Syncytial Virus Matrix Protein-Host Protein Interactions as Targets for Therapeutics

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1043511

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Respiratory syncytial virus (RSV) causes more deaths in winter than influenza, being the major cause of viral pneumonia in infants worldwide, and a potent lower respiratory pathogen in the elderly and immunosuppressed adults. The present proposal will apply a range of techniques to search for new inhibitors of viral infection which target host-virus interactions, as the first step towards new generation anti-viral agents to treat RSV infection.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $686,885.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Virology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anti-viral development | child health | nuclear transport | respiratory syncytial virus | therapeutic target

Related Links